We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World’s First Brain Stimulation Treatment for Neurological Diseases Uses Ultrasound Technology

By MedImaging International staff writers
Posted on 19 Dec 2023
Image: Annotated illustration of brain tissue and proposed project technology (Photo courtesy of The University of Melbourne)
Image: Annotated illustration of brain tissue and proposed project technology (Photo courtesy of The University of Melbourne)

The effectiveness of drug treatments for individuals with neurological diseases like Parkinson's disease and epilepsy often diminishes over time, necessitating alternative therapeutic approaches. Movement symptoms in such conditions are typically the result of disorganized neural signals in the brain areas governing movement. Deep brain stimulation, a technique that disrupts these erratic signals, has shown promise in managing tremors and other movement-related symptoms. It also holds the potential for controlling, and possibly even preventing, seizures in epilepsy patients. Now, researchers are exploring a groundbreaking brain stimulation treatment that employs ultrasound, delivered through a device located inside a brain blood vessel, to address symptoms of neurological disorders.

A group of biomedical engineers at The University of Melbourne (Victoria, Australia), along with their colleagues, are developing ‘endovascular focused ultrasound’ technology, which could substantially enhance the lives of those with neurological diseases. Currently, electrical brain stimulation is a treatment option, but it requires invasive brain surgery to implant electrodes and often lacks precision in stimulating the correct brain regions. The accuracy of electrode placement is crucial; slight misplacements can lead to diminished efficacy and unintended side effects. The team's endovascular-focused ultrasound technology, anticipated to be available in over a decade, presents a safer alternative to existing treatments, avoiding the need for open brain surgery and utilizing ultrasound instead of electrical stimulation.

This innovative method involves inserting an array of tiny transducers permanently into a brain blood vessel, likely through the jugular vein, akin to current stent insertion practices in the heart and brain. These transducers would be connected to a chest-implanted device similar to a pacemaker, which would power and control the ultrasound stimulation. Thanks to advancements in nanofabrication technology, which is also used in computer chip manufacturing, researchers can produce extraordinarily small ultrasound transducers. These transducers are fine enough to fit inside a blood vessel, being narrower than human hair. When arranged in an array, they can precisely focus the ultrasound beam on a specific brain target, minimizing stimulation to surrounding tissue. The team aims for a successful initial demonstration of this novel brain stimulation method within a three-year project timeline and is hopeful that the first human trials could commence by 2030.

“We have demonstrated preliminary safety and efficacy of implanting neurotechnology within cortical blood vessels to enable people with paralysis to control external equipment with their minds,” said Professor Nicholas Opie from the University of Melbourne Department of Medicine. “Ultrasound is a new method of stimulating the brain and has the potential to provide transformative treatments for people with neurological disorders such as Parkinson’s, epilepsy and depression.”

Related Links:
The University of Melbourne 

Pocket Fetal Doppler
CONTEC10C/CL
Digital Radiographic System
OMNERA 300M
X-Ray Generator
Advantage Plus Generators
X-Ray Illuminator
X-Ray Viewbox Illuminators

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.